Free Trial
TSE:OGI

Organigram 5/14/2024 Earnings Report

Organigram logo
C$1.85 -0.02 (-1.07%)
As of 11:08 AM Eastern

Organigram EPS Results

Actual EPS
-C$0.16
Consensus EPS
-C$0.08
Beat/Miss
Missed by -C$0.08
One Year Ago EPS
N/A

Organigram Revenue Results

Actual Revenue
$37.63 million
Expected Revenue
$38.20 million
Beat/Miss
Missed by -$570.00 thousand
YoY Revenue Growth
N/A

Organigram Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Organigram Earnings Headlines

Buffett’s Next Move Could Shock Wall Street
In just a few weeks, a move decades in the making could be revealed — and when it is, it could ignite the next great gold rush. Savvy insiders are quietly positioning now… before Buffett makes it official. Garrett Goggin has already pinpointed four tiny-gold-miners that could 100X once the announcement hits. It’s the perfect moment to be greedy — before the herd wakes up.
See More Organigram Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Organigram? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Organigram and other key companies, straight to your email.

About Organigram

Organigram (TSE:OGI) Inc. is a Canadian licensed producer of cannabis products. Organigram focuses on producing exceptional, indoor-grown cannabis for patients and adult recreational consumers, as well as developing global business partnerships.

View Organigram Profile

More Earnings Resources from MarketBeat